Latest TroVax Stories
COPENHAGEN, Denmark, April 28, 2015 /PRNewswire/ -- DanDrit Biotech USA, Inc.
ThermoDox® Continues to Demonstrate Impressive Local Response Rate in Highly Refractory Patients LAWRENCEVILLE, N.J., April 15, 2015 /PRNewswire/ -- Celsion Corporation (NASDAQ:
Patients Too Sick for Enrollment in Phase III Trial for Newly Diagnosed GBM BETHESDA, Md., March 27, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc.
--- Significant Survival Benefit Observed in Pre-Specified Subgroups Including Patients with Brain Metastases and Patients with Baseline Liver Metastases --- SAN FRANCISCO, March
LUGANO, Switzerland and COPENHAGEN, Denmark, February 5, 2015 /PRNewswire/ -- - Elsiglutide is a GLP-2 receptor agonist with potential as a first-ever therapy to help cancer
BOTHELL, Wash. and VANCOUVER, B.C., Sept.16, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc.
AUSTIN, Texas, Sept.
ENSPIRIT Trial to Continue as Planned Following Completion of the First of Two Interim Futility Analyses BOTHELL, Wash. and VANCOUVER, British Columbia, Aug.
Trial Progressing On Track; BETHESDA, Md., Aug.
- a slit in a tire to drain away surface water and improve traction.